drugset / Trial / NCT00731276

Irinotecan in Treating Asian Patients With Solid Tumors

NCT00731276 ↗

Phase 1 Completed 18 enrolled National Cancer Centre, Singapore
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan in treating Asian patients with solid tumors.

Timeline

Start
2008-04-03
Primary completion
2015-11
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule — Intravenous